[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-1760":32,"stock-themes-1760":121},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":120},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"1760","寶齡富錦","寶齡富錦生技股份有限公司","sii","stock","生技醫療業","2018-01-23","張立秋","江宗明",857390130,85739013,"1976-01-07","http:\u002F\u002Fwww.pbf.com.tw","台北市南港區園區街3號16F(F棟)","PBF","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":63,"ret_60d":64,"ret_ytd":65,"open":51,"high":66,"low":67,"pe":68,"pb":69,"dy":70,"foreign_net_1d":71,"foreign_net_5d":72,"trust_net_1d":73,"trust_net_5d":73,"dealer_net_1d":73,"dealer_net_5d":73,"foreign_holding_pct":74,"margin_balance":75,"margin_chg":76,"short_balance":77,"short_chg":78,"large_holder_pct":79,"large_holder_chg_1w":73,"large_holder_chg_4w":73,"holders_date":80,"high_52w":81,"low_52w":82,"rev_period":83,"rev_yoy":84,"eps_period":85,"eps":86,"spark":87},54,-1.1999999999999957,-0.021739130434782594,0.0018552875695734272,-0.018181818181818077,92323,4998637,4629906702,[60,61,62],"rev_yoy","eps_yoy","foreign_buy_5d",55.199999999999996,-0.12195121951219512,-0.11404561824729875,55,53.9,21.51,2.47,3.7,-30000,42053,0,10.9,1081,-11,2,-2,33.89,"2026-10-09",76.4,53.4,"2026-09",1.05,"2026-Q2",0.45613961424834176,[88,89,90,90,91,91,92,93,94,95,96,97,98,99,98,100,101,101,98,97,96,102,103,104,98,97,105,105,102,96,103,95,95,106,107,107,108,109,110,66,111,67,112,113,114,113,51,113,67,115,67,116,116,116,67,115,117,118,119,51],60,61.4,61.5,61.1,60.5,59.7,58.7,58,58.6,59,58.8,59.6,59.1,59.3,58.4,58.3,58.1,58.2,57.2,56.3,56.4,56,55.9,54.1,53.8,53.6,54.4,53.7,54.6,54.3,55.7,55.2,"20261013-fcba10",[122],{"theme":123,"segment":130,"tier":131,"role":132,"relevance":133,"note":134,"peers":135,"upstream":205,"downstream":211},{"id":66,"slug":124,"name":125,"category":126,"ret_1d":129},"new-drugs","新藥研發",{"slug":127,"name":128},"biotech","生技醫療",-0.025792561311777984,"新藥開發與臨床","upstream","niche","mid","腎臟病用藥與保健品",[136,151,162,172,183,195],{"code":137,"name":138,"role":139,"relevance":140,"note":141,"industry":39,"close":17,"chg_pct":142,"ret_5d":143,"ret_20d":144,"mcap":145,"turnover":146,"signals":147},"6446","藥華藥","leader","high","血液疾病新藥，已有上市產品",-0.016877637130801593,-0.021008403361344352,-0.11742424242424243,492134794500,1315551970,[60,148,61,149,150],"rev_yoy_3m","trust_buy_5d","holders_up",{"code":152,"name":153,"role":132,"relevance":140,"note":154,"industry":39,"close":155,"chg_pct":156,"ret_5d":157,"ret_20d":158,"mcap":159,"turnover":160,"signals":161},"4743","合一","傷口與皮膚新藥",47.55,-0.03451776649746208,0.009554140127388422,0.04390779363336983,22849367925,83204957,[61,62,150],{"code":163,"name":164,"role":132,"relevance":140,"note":165,"industry":39,"close":103,"chg_pct":166,"ret_5d":167,"ret_20d":168,"mcap":169,"turnover":170,"signals":171},"4147","中裕","愛滋病抗體藥，已有上市產品",-0.036363636363636376,-0.028333333333333433,-0.0535714285714286,15927699919.999998,72544406,[],{"code":173,"name":174,"role":132,"relevance":140,"note":175,"industry":39,"close":176,"chg_pct":177,"ret_5d":178,"ret_20d":179,"mcap":180,"turnover":181,"signals":182},"4162","智擎","新藥開發與授權",56.5,-0.013961605584642212,0.027272727272727337,0.031021897810219023,8230784400,14152607,[60,61],{"code":184,"name":185,"role":186,"relevance":140,"note":187,"industry":39,"close":188,"chg_pct":189,"ret_5d":190,"ret_20d":191,"mcap":192,"turnover":193,"signals":194},"6550","北極星藥業-KY","challenger","癌症新藥開發",15.9,-0.027522935779816682,-0.01851851851851838,-0.19039113027409926,14227203930.000002,8240813,[61,62,150],{"code":196,"name":197,"role":186,"relevance":140,"note":187,"industry":39,"close":198,"chg_pct":199,"ret_5d":200,"ret_20d":201,"mcap":202,"turnover":203,"signals":204},"4174","浩鼎",55.8,-0.029565217391304355,0.20779220779220764,1.1338432122370938,7342146534.599999,43742268,[61],[206],{"id":109,"slug":207,"name":208,"category":209,"ret_1d":210},"cdmo-generics","CDMO 與學名藥",{"slug":127,"name":128},-0.010249642314885767,[]]